Calcilytic NPSP795 Increases Plasma Calcium and PTH in an Autosomal Dominant Hypocalcemia Type 1 Mouse Model.
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024
Project: CaSR Biomedicine
Updated at: 28-04-2024